Robeauté

🌍 Robeauté on the Road 🌎 October has been a busy and rewarding month for our mighty team, as we showed up in Turin and Vienna, San Diego, New York, San Francisco and Los Angeles – with the central goal of building the next era of brain health. 🇮🇹 At Italian Tech Week, Joana Cartocci shared the stage with Vivodyne, General Catalyst and LocalGlobe to explore how cutting edge technology is helping us treat conditions once thought untreatable, and the necessary mental shift to get us there. 🧠 In New York, Quentin François joined in on inspiring industry conversations at Mount Sinai Health System Brain-Computer Interface Symposium. 🇺🇸 In San Diego, at The MedTech Conference co-founders Bertrand Duplat and Joana Cartocci were among global Medtech leaders talking about moving swiftly from prototype to patient impact responsibly and collaboratively, working closely with regulators and corporate partners. 🎯 In Los Angeles for Congress of Neurological Surgeons (CNS), Quentin François and Oscar Gallardo proudly presented Robeauté’s poster, and connected with neurosurgeons and innovators, including our partners at Brainlab, as well as Avatar Medical, and Hemerion Therapeutics. 🇦🇹 Our Referent Neurosurgeon Arthur André was seen in Vienna sharing our research results at the European Association of Neurosurgical Societies (EANS) with more than 2400 participants. ...AND to cap off this extremely productive month, we’re beyond proud to see Joana Cartocci featured in Sifted’s inaugural 100 Women in Tech in Europe crafted by SISTAFUND STATION F., celebrating women shaping the future of technology and health across the continent 🌟 Plenty of miles, important conversations and groundbreaking ideas: fuelling our mission to rethink what used to be impossible in brain health.

☀️ Holding onto Summer a while longer as we think back to the beautiful event we curated in Paris in July: The Brain Gardeners’ Club. 🌱🧠 The second edition of the Brain Gardeners’ Club brought together pioneers building the future of brain health. We came together across disciplines — scientists, clinicians, entrepreneurs, ethicists, and visionaries — around a shared conviction: ✨ Brain medicine is entering its most transformative decade. ✨ Like neurons, we are stronger when we connect. ✨ Healing comes before enhancement. Always. Robeauté, in partnership with AP-HP, Assistance Publique - Hôpitaux de Paris and @Hôtel-Dieu, hosted a day of conversations in one of the most inspiring locations in Paris. This gathering was not about incremental change. It was about embracing a Kuhnian shift: moving from marginal improvements to bold breakthroughs. This movement is rooted in three principles: 🔬 Radical precision — interventions that are non-invasive when possible, minimally invasive when necessary, always accurate at the cellular and circuit level. ⚡ From protocols to cures — moving beyond temporary fixes to lasting solutions.  🤝 Ecosystem over ego — breakthroughs will come from networks, not silos. 📽️ Here’s a glimpse of this year’s salon - that has quickly become fertile ground for impressive collaborations and inspiring cross-pollination. 🌍 Thank you in particular to all those who made the journey from across the world to share their work and insights. Your contribution was priceless. The Brain Gardeners’ Club is set to grow globally and host salons in multiple locations around the world —> stay tuned for the next edition. ✉️ The question is no longer whether to act. It’s how bold we’re willing to be. And we’re here for it. Bertrand Duplat, Nicolas Castoldi, Joana Cartocci, Arthur André, Sandeep Kunwar, Matthew MacDougall, Viviane Tabar, Calvin Kuo, Benoit Larrat, PhD, Chloé Geoffroy, François Berger, Peter Vajkoczy, Laurent Levy, Jacques Carolan, Emmanuel Bacry, Philippe Domenech, Johan PALLUD, Mariusz Olejniczak, Anne Osdoit, Sébastien Froelich, Tariq Krim, Roxann Stafford MBA (she/her) ✨

Nous sommes ravis d’avoir rejoint “La French Care”. ⚡️ A rising tide lifts all ships.

🎉 Awesome news we have been waiting for! We are thrilled to announce that Robeauté has been selected as one of the winners of the EIC Accelerator program! Thanks to the European Innovation Council and SMEs Executive Agency (EISMEA) we are one step closer to bringing our microrobot to ORs around the world. This funding will accelerate our mission to improve patient care and transform neurosurgical procedures, making them safer, more efficient, and less invasive. Thank you to the EIC for supporting this vision. 🌟We are excited for what lies ahead as we continue pushing the boundaries of medical innovation. A heartfelt thank you to the wonderful team at Zaz Ventures for helping us pull this off. 🙌 #EUeic #deeptech #Medtech #robotics #innovation

Yesterday we had the pleasure of celebrating World Cancer Day by closing the Paris Saclay Cancer Cluster (PSCC) Innovation Forum with a presentation of how Robeauté aims to work with the Pharmaceutical and Biotech industry to deliver targeted therapies for the effective treatment of brain disease, starting with #Cancer. « Cancer is a moving target », as Léa Perles pointed out - and in the brain it remains even more obscure due to the lack of minimally invasive access. We need better tools to collect patient-specific local data informing physicians on the best treatment and deliver them directly to the site of interest, bypassing the inefficacies of a systemic approach.  Robeauté’s microrobot will be able to do just that - Diagnose, treat and monitor. Thank you to the audience for their attention and to the esteemed judges for awarding Robeauté the « Coup de Cœur » du Jury. It is key for Pharma & Medtech to work together in order to unlock innovative therapeutic solutions for patients around the world. Thank you to the Paris Saclay Cancer Cluster (PSCC) and Patricia Zerr, PhD MBA for highlighting our approach and for gathering such a formidable group of people. See you next year! ✌🏼

📣 The news is out! Robeauté has brought together a remarkable team of Deeptech and Medtech investors in a $28 million series A round, to take us all the way to patients! 🚀 We are excited to be joined by Plural, Cherry Ventures, Kindred Ventures, LocalGlobe, Think Health and Brainlab, whose combined experience contributes operational mastery, scientific and medical excellence and commercial power. This new funding will enable: 🧠 acceleration of our neurosurgical microrobot through preclinical trials all the way to first-in-human studies 🤝 strengthening medical and industrial collaborations to explore the device’s full platform potential.  🇺🇸 setting up operations in the US to support this new phase ⚡️growing the team with key hires in R&D, Regulatory and Business Development. We believe that the next few years are going to be critical for neuroscience, with the rise of companies who’s innovations will shape our understanding of the brain and our ability to address neurological disorders in a much more targeted way, to radically improve patient outcomes.  Robeauté intends to play a critical role in that conversation, enabling the diagnosis, treatment and monitoring of brain pathologies through its neurosurgical microrobot. Follow along on this Fantastic Voyage to the brain. Find Fortune’s exclusive of the funding announcement insightfully written by Jeremy Kahn - in the comment section below, as well as some more thought-provoking material.  ✨ Bertrand Duplat Joana Cartocci Quentin François Ali Oulmas Arthur André

🥇🤖 We’re on a roll!  Robeauté won 1st Place at the 13th MEDICA Start-Up Competition, held yesterday at the MEDICA Innovation Forum in Düsseldorf—the world’s largest medical trade fair. Thank you to the brilliant jury for this recognition and to each of the 12 remarkable participants pushing the boundaries of health tech, from #robotics and AI to health apps and lab diagnostics. Joining the MEDICA - Leading International Trade Fair ecosystem is a true honor and an exciting step forward. Surrounded by global health tech leaders and innovation-driven peers, we’re exactly where we aspire to be: accelerating solutions that reimagine health and improve lives. Here’s to a future filled with health innovation and impactful change! ✨